Chapter 16. Biopharmaceuticals and the Industrial Environment

  1. Prof. Dr. Gerd Gellissen1,2
  1. Georg Melmer

Published Online: 19 MAY 2005

DOI: 10.1002/3527603670.ch16

Book Title

Production of Recombinant Proteins: Novel Microbial and Eukaryotic Expression Systems

Production of Recombinant Proteins: Novel Microbial and Eukaryotic Expression Systems

Additional Information

How to Cite

Melmer, G. (2005) Biopharmaceuticals and the Industrial Environment, in Production of Recombinant Proteins: Novel Microbial and Eukaryotic Expression Systems (ed G. Gellissen), Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim, FRG. doi: 10.1002/3527603670.ch16

Editor Information

  1. 1

    MedArtis Pharmaceuticals GmbH, Pauwelsstr. 19, 52047 Aachen, Germany

  2. 2

    Ringstrasse 30, 42489 Wülfrath, Germany

Author Information

  1. MedArtis Pharmaceuticals GmbH, Pauwelsstr. 19, 52047 Aachen, Germany

Publication History

  1. Published Online: 19 MAY 2005
  2. Published Print: 4 NOV 2004

ISBN Information

Print ISBN: 9783527310364

Online ISBN: 9783527603671

SEARCH

CHAPTER TOOLS

Get PDF (143K)

Keywords:

  • production of recombinant proteins;
  • novel microbial and eucaryotic expression systems;
  • biopharmaceuticals;
  • industrial environment;
  • early success stories;
  • current and future markets;
  • clinical development of biopharmaceuticals;
  • drug delivery and modification of proteins;
  • expression systems for commercial drug manufacture

Summary

This chapter contains sections titled:

  • Introduction

  • Early Success Stories

  • The Bumpy Road Appeared

  • The Breakthrough in Many Areas

  • Which are the Current and Future Markets?

  • The Clinical Development of Biopharmaceuticals

  • Drug Delivery and Modification of Proteins

  • Expression Systems for Commercial Drug Manufacture

  • Will Demand Rise?

  • Conclusions and Perspectives

  • References

  • Subject Index

Get PDF (143K)